Immunotherapy in Tel Aviv typically costs from $9,800 to $15,500. Total expenses depend on the specific drug protocol, cancer stage, and whether treatment involves advanced cell engineering. Patients save around 88% compared to the US, where this procedure costs $30,000 on average. Standard packages in Tel Aviv often include hospital stays and professional transfers to the clinic.
- Immunotherapy with Keytruda (Pembolizumab): $8,500 to $11,500 for targeted oncology.
- CAR T-cell therapy: Price on request
to Price on request
, includes complex genetic cell modification.
- Immunotherapy for prostate cancer: $22,500 to $46,000 for targeted protocols.
- Biological therapy: $9,500 to $16,200 for immune system stimulation.
Bookimed Expert Insight: Tel Aviv serves as Israel's primary hub for clinical oncology research and high-volume immunotherapy centers. Clinics here offer unique access to the Israeli National Genomic Medicine Initiative for precise treatment selection. Sourasky Medical Center (Ichilov) achieves a 90% success rate by integrating computational biology into patient protocols. Expert Ari Raphael specifically leads trials using liquid biopsies to predict patient responses before treatment begins.